Association of Polymorphisms in CYP2C19 with the Efficacy of Clopidogrel Therapy in South Indian Patients Undergoing Percutaneous Coronary Intervention

Conclusion: We observed that the CYP2C19*2 and CYP2C19*1/*2 are the major determinants of clopidogrel efficacy. Acute stent thrombosis was observed in patients carrying CYP2C19*2 variant allele.Keywords:Acute coronary syndrome,Antiplatelet therapy,Clopidogrel,Percutanous coronary intervention,Pharmacogenetics.View:PDF (645.78 KB)Full TextClick here to download the PDF file.‹ Stenting of Aortic Coarctation: Immediate and Intermediate Follow-up ResultsStudy of Metabolic Syndrome and Its Components Among Kurnool District Population of Andhra Pradesh with Different Ethnic Backgrounds ›

Source: Journal of Cardiovascular Disease Research - July 4, 2017 Category: Cardiology Authors: yunus Source Type: research